Why the study?
Does culprit lesion only PCI improve cost-effectiveness and QALY gains compared to immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock?
Does culprit lesion only PCI improve cost-effectiveness and QALY gains compared to immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock?
Long-term horizon analysis is necessary to accurately capture the QALY gains and cost-effectiveness of culprit-lesion-only PCI versus multivessel PCI in AMI with cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Long-term horizons needed to capture CO-PCI QALY gains; leaves open whether this alters cost-effectiveness in cardiogenic shock.
The estimates of cost-effectiveness for CO-PCI vs. MV-PCI have been shown to change depending on the time horizon and type of economic evaluation performed. The results favoured a long-term horizon analysis for avoiding underestimation of QALY gains from the CO-PCI arm.
No takes yet. Share an insight, caveat, or question.
Robles‐Zurita et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: